Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
Boehringer Ingelheim
Daiichi Sankyo
US Department of Justice

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,124,363

« Back to Dashboard

Which drugs does patent 6,124,363 protect, and when does it expire?

Patent 6,124,363 protects TIKOSYN and is included in one NDA. There has been one Paragraph IV challenge on Tikosyn.

This patent has fifty-one patent family members in forty-six countries.

Summary for Patent: 6,124,363

Title: Dofetilide polymorphs
Abstract:The invention relates to the substantially pure dofetilide polymorphs P162, P162a and P143, and to processes for the preparation of, compositions containing and to the uses of, such polymorphs.
Inventor(s): Appleby; Ian Colin (Sandwich, GB), Newbury; Trevor Jack (Sandwich, GB), Nichols; Gary (Sandwich, GB)
Assignee: Pfizer Inc. (New York, NY)
Application Number:09/423,986
Patent Claim Types:
see list of patent claims
Compound; Process; Composition; Dosage form; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
PfizerTIKOSYNdofetilideCAPSULE;ORAL020931-001Oct 1, 1999ABRXYesNo► Subscribe► Subscribe► Subscribe
PfizerTIKOSYNdofetilideCAPSULE;ORAL020931-002Oct 1, 1999ABRXYesNo► Subscribe► Subscribe► Subscribe
PfizerTIKOSYNdofetilideCAPSULE;ORAL020931-003Oct 1, 1999ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,124,363

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9722662Oct 27, 1997
PCT Information
PCT FiledOctober 09, 1998PCT Application Number:PCT/EP98/06641
PCT Publication Date:May 06, 1999PCT Publication Number: WO99/21829

International Patent Family for Patent: 6,124,363

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Slovenia1027329► Subscribe
Saudi Arabia1168► Subscribe
Portugal1027329► Subscribe
Poland197379► Subscribe
Poland340805► Subscribe
Peru122199► Subscribe
Panama8462001► Subscribe
African Intellectual Property Organization (OAPI)11350► Subscribe
New Zealand503785► Subscribe
Norway325630► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: